BIM
ALXN

Beach Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Beach Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,385
Closed -$455K – 48
2015
Q4 		$455K Buy
+2,385
New +$417K 0.8% 39
2015
Q3 		– Sell
-5,940
Closed -$1.07M – 54
2015
Q2 		$1.07M Buy
5,940
+850
+17% +$147K 1.61% 24
2015
Q1 		$882K Hold
5,090
– – 1.3% 35
2014
Q4 		$942K Sell
5,090
-110
-2% -$20.4K 1.32% 36
2014
Q3 		$862K Buy
+5,200
New +$854K 1.26% 34

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Beach Investment Management's ALXN Position: Q1 2016 in Review

Beach Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q1 2016, closing a stake of 2,385 shares — an estimated $455K sold.

Beach Investment Management first reported a position in ALXN in Q3 2014 and held it in 5 quarters. The position peaked at $1.07M in Q2 2015. 518 funds tracked by Wall St. Rank hold ALXN as of Q1 2016.

  • Beach Investment Management reported no remaining Alexion Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Beach Investment Management sold 2,385 Alexion Pharmaceuticals shares in Q1 2016, an estimated $455K.
  • Beach Investment Management first reported a position in Alexion Pharmaceuticals in Q3 2014 and held it in 5 quarters.
  • Beach Investment Management's Alexion Pharmaceuticals position peaked at $1.07M in Q2 2015.
  • 518 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2016.

Based on Beach Investment Management's 13F filing for Q1 2016, filed 12 May 2016.